Detalhe da pesquisa
1.
KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements.
Nature
; 598(7882): 682-687, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671158
2.
Vascular mimicry as a facilitator of melanoma brain metastasis.
Cell Mol Life Sci
; 81(1): 188, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38635031
3.
A bedside to bench study of anti-PD-1, anti-CD40, and anti-CSF1R indicates that more is not necessarily better.
Mol Cancer
; 22(1): 182, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964379
4.
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma.
Cell Mol Life Sci
; 79(7): 377, 2022 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35737114
5.
Melanoma brain metastases have lower T-cell content and microvessel density compared to matched extracranial metastases.
J Neurooncol
; 152(1): 15-25, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32974852
6.
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Lancet Oncol
; 21(5): 655-663, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32251621
7.
[11C]Methionine and [11C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation Necrosis.
Mol Imaging
; 19: 1536012120968669, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147119
8.
PLEKHA5 regulates tumor growth in metastatic melanoma.
Cancer
; 126(5): 1016-1030, 2020 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769872
9.
Complications associated with immunotherapy for brain metastases.
Curr Opin Neurol
; 32(6): 907-916, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577604
10.
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Lancet Oncol
; 17(7): 976-983, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267608
11.
MEK targeting in N-RAS mutated metastatic melanoma.
Mol Cancer
; 13: 45, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24588908
12.
Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma.
Cancer Cell Int
; 14(1): 4, 2014 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24423208
13.
Melanocortin-1 Receptor Expression as a Marker of Progression in Melanoma.
JCO Precis Oncol
; 8: e2300702, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662983
14.
Melanocortin 1 receptor (MC1R) expression as a marker of progression in melanoma.
Res Sq
; 2023 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790306
15.
Lenvatinib or anti-VEGF in combination with anti-PD-1 differentially augments antitumor activity in melanoma.
JCI Insight
; 8(7)2023 04 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36821392
16.
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586773
17.
Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36898736
18.
Inhibition of renalase drives tumour rejection by promoting T cell activation.
Eur J Cancer
; 165: 81-96, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219026
19.
Location matters: LAG3 levels are lower in renal cell carcinoma metastatic sites compared to primary tumors, and expression at metastatic sites only may have prognostic importance.
Front Oncol
; 12: 990367, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36313654
20.
Spatially resolved analysis of the T cell immune contexture in lung cancer-associated brain metastases.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670827